Lindbrook Capital’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $11.3K | Sell |
516
-157
| -23% | -$3.43K | ﹤0.01% | 1598 |
|
|
2024
Q4 | $21.5K | Buy |
673
+365
| +119% | +$11.6K | ﹤0.01% | 1249 |
|
|
2024
Q3 | $8.88K | Buy |
308
+199
| +183% | +$5.74K | ﹤0.01% | 1736 |
|
|
2024
Q2 | $4.18K | Sell |
109
-195
| -64% | -$7.48K | ﹤0.01% | 2082 |
|
|
2024
Q1 | $17.9K | Hold |
304
| – | – | ﹤0.01% | 1270 |
|
|
2023
Q4 | $18.2K | Buy |
304
+155
| +104% | +$9.28K | ﹤0.01% | 1232 |
|
|
2023
Q3 | $5.67K | Sell |
149
-75
| -33% | -$2.85K | ﹤0.01% | 1708 |
|
|
2023
Q2 | $20.4K | Sell |
224
-52
| -19% | -$4.74K | ﹤0.01% | 1077 |
|
|
2023
Q1 | $18.2K | Sell |
276
-6
| -2% | -$396 | ﹤0.01% | 1117 |
|
|
2022
Q4 | $14.6K | Sell |
282
-16
| -5% | -$827 | ﹤0.01% | 1238 |
|
|
2022
Q3 | $20K | Buy |
298
+197
| +195% | +$13.2K | ﹤0.01% | 973 |
|
|
2022
Q2 | $5K | Buy |
101
+8
| +9% | +$396 | ﹤0.01% | 1520 |
|
|
2022
Q1 | $5K | Buy |
93
+55
| +145% | +$2.96K | ﹤0.01% | 1566 |
|
|
2021
Q4 | $2K | Hold |
38
| – | – | ﹤0.01% | 1741 |
|
|
2021
Q3 | $1K | Hold |
38
| – | – | ﹤0.01% | 1669 |
|
|
2021
Q2 | $2K | Hold |
38
| – | – | ﹤0.01% | 1551 |
|
|
2021
Q1 | $2K | Hold |
38
| – | – | ﹤0.01% | 1507 |
|
|
2020
Q4 | $2K | Hold |
38
| – | – | ﹤0.01% | 1419 |
|
|
2020
Q3 | $1K | Hold |
38
| – | – | ﹤0.01% | 1501 |
|
|
2020
Q2 | $1K | Buy |
+38
| New | +$1K | ﹤0.01% | 1509 |
|